Michael Egger, MD
Surgical Oncology · Louisville, KYNPI 1689846982
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 67.0% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $756 and has fallen 50.3% since, to $375 in 2025.
Across 77 payments — averaging $41.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Davol Inc.$349
- Intuitive Surgical$115
- Amgen$94
- Johnson & Johnson$66
- Sanofi$60
- plus $381 from 15 others
What the payments were for
- Food & beverage$3,230100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $2,164 |
| Davol Inc. | 3 | $349 |
| Intuitive Surgical | 1 | $115 |
| Amgen | 7 | $94 |
| Johnson & Johnson(2 entities) | 2 | $66 |
| Sanofi | 3 | $60 |
| Astellas Pharma US Inc | 3 | $44 |
| Kerecis Limited | 1 | $36 |
| Bristol Myers Squibb | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Genentech, Inc. | 1 | $32 |
| Avita Medical Americas, LLC | 1 | $30 |
| Merck | 2 | $27 |
| Vertex | 1 | $25 |
| Mentor Worldwide LLC | 1 | $24 |
| Incyte Corporation | 2 | $24 |
| Cerus Corporation | 1 | $16 |
| Medical Device Business Services, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Bayer | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,230 in reported general payments places this provider in the 55th percentile of 29 surgical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $243 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $104 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Louisville
- Robert MartinLouisville$483K
- Charles ScogginsLouisville$15K
- Nicolas AjkayLouisville$11K
- Prejesh PhilipsLouisville$9K
- Amy QuilloLouisville$908
- Alissa DollLouisville$439
- Kelly McMastersLouisville$438
- Neal BhutianiLouisville$398
- Allison HatmakerLouisville$148
- Michael EdwardsLouisville$27
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.